Clinical Trial Update: S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer [Phase 3]

View source ↗

Summary

A Phase 3 study (SWOG S0200) comparing carboplatin with or without Doxil in recurrent ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Doxil (liposomal doxorubicin)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Ovarian Cancer, Peritoneal Cavity Cancer | Phase 3 | Status: COMPLETED